V Waters

Summary

Affiliation: The Hospital for Sick Children
Country: Canada

Publications

  1. doi request reprint Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada Electronic address
    J Cyst Fibros 14:770-6. 2015
  2. doi request reprint Cystic fibrosis microbiology: Advances in antimicrobial therapy
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada Electronic address
    J Cyst Fibros 14:551-60. 2015
  3. doi request reprint Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients
    Valerie J Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto Electronic address
    J Cyst Fibros 14:755-62. 2015
  4. doi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Cochrane Database Syst Rev 12:CD010004. 2014
  5. doi request reprint Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 12:482-6. 2013
  6. doi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 12:CD010004. 2012
  7. doi request reprint Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 11:CD009528. 2012
  8. doi request reprint Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    V Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
    Eur J Clin Microbiol Infect Dis 31:3341-50. 2012
  9. doi request reprint Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Eur Respir J 40:61-6. 2012
  10. doi request reprint Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 11:8-13. 2012

Detail Information

Publications14

  1. doi request reprint Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada Electronic address
    J Cyst Fibros 14:770-6. 2015
    ..Although extended antibiotic duration has not been shown to be associated with improved outcomes in CF overall, it is not known whether there is a subset of patients who may benefit from longer treatment courses...
  2. doi request reprint Cystic fibrosis microbiology: Advances in antimicrobial therapy
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada Electronic address
    J Cyst Fibros 14:551-60. 2015
    ..Continued development of effective antimicrobial agents that can function in the conditions encountered in the CF lung, such as against bacterial biofilm growth and under anaerobic conditions, is needed. ..
  3. doi request reprint Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients
    Valerie J Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto Electronic address
    J Cyst Fibros 14:755-62. 2015
    ..The objective of this study was to identify factors associated with lung function response to antibiotic treatment of pulmonary exacerbations...
  4. doi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Cochrane Database Syst Rev 12:CD010004. 2014
    ....
  5. doi request reprint Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 12:482-6. 2013
    ..The goal of this study was to determine the effect of chronic S. maltophilia infection on mortality and the need for lung transplantation in a longitudinal study of children and adults with CF...
  6. doi request reprint Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 12:CD010004. 2012
    ....
  7. doi request reprint Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
    Valerie Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada
    Cochrane Database Syst Rev 11:CD009528. 2012
    ..Therefore, choosing antibiotics based on biofilm rather than conventional antimicrobial susceptibility testing could potentially improve response to treatment of Pseudomonas aeruginosa in people with cystic fibrosis...
  8. doi request reprint Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    V Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
    Eur J Clin Microbiol Infect Dis 31:3341-50. 2012
    ..aeruginosa isolates from CF patients. MLST had the greatest predictive value in identifying strains as unique and, thus, has the potential to be a cost-efficient, high-throughput, first-pass typing method...
  9. doi request reprint Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
    Eur Respir J 40:61-6. 2012
    ..Time between exacerbations, specifically ≤ 6 months between exacerbations, plays an important contribution to overall lung function decline. These findings support using time to next exacerbation as a clinical end-point for CF trials...
  10. doi request reprint Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Canada M5G 1X8
    J Cyst Fibros 11:8-13. 2012
    ..The aim of this study was to determine the effect of chronic S. maltophilia infection and associated antimicrobial therapy on the recovery of forced expiratory lung volume in 1s (FEV(1)) following pulmonary exacerbation...
  11. ncbi request reprint New treatments for emerging cystic fibrosis pathogens other than Pseudomonas
    Valerie Waters
    Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada
    Curr Pharm Des 18:696-725. 2012
    ....
  12. doi request reprint Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
    Am J Respir Crit Care Med 183:635-40. 2011
    ..maltophilia infection on CF lung disease is unknown...
  13. doi request reprint Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children
    Valerie Waters
    Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
    Pediatr Infect Dis J 28:582-7. 2009
    ..A case-control study in children was done to identify the risk factors for being positive for Bordetella pertussis by polymerase chain reaction (PCR)...
  14. pmc Live viral vaccines in a DiGeorge syndrome patient
    V Waters
    Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, Canada
    Arch Dis Child 92:519-20. 2007
    ..Although live viral vaccines have been used safely in some children with DiGeorge syndrome, there are insufficient data to recommend their routine use in those with severe immunodeficiency...